Compare INTS & LESL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INTS | LESL |
|---|---|---|
| Founded | 2012 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4M | 12.4M |
| IPO Year | 2021 | 2020 |
| Metric | INTS | LESL |
|---|---|---|
| Price | $4.04 | $0.65 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $38.00 | $2.54 |
| AVG Volume (30 Days) | 25.0K | ★ 1.6M |
| Earning Date | 05-07-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,241,915,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.22 | $0.27 |
| 52 Week High | $8.06 | $12.53 |
| Indicator | INTS | LESL |
|---|---|---|
| Relative Strength Index (RSI) | 41.36 | 28.68 |
| Support Level | $3.99 | N/A |
| Resistance Level | $5.00 | $1.65 |
| Average True Range (ATR) | 0.28 | 0.24 |
| MACD | -0.03 | 0.13 |
| Stochastic Oscillator | 23.74 | 2.35 |
Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products, including chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company serves residential pool, residential spa, professional pool, and commercial pool consumers and markets its products through over 1,000 company-operated locations in 39 states and e-commerce websites, operating only in the United States. It operates mainly in the pool and spa aftermarket industry and offers regularly purchased, non-discretionary maintenance items, along with installation and repair services for pool and spa equipment.